Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
VMS Rehab Systems, Inc. (VRSYF)
Ottawa, ON, CA
VMS Rehab Systems, Inc. maintains operations across two distinct fields: generic pharmaceuticals and home healthcare. A significant part of its pharmaceutical efforts involves the creation and rigorous evaluation of generic versions of tadalafil. Furthermore, within its home healthcare division, the company provides specialized orthopedic wedge seat cushions. These cushions are specifically engineered to alleviate pain and discomfort arising from various lower body ailments, including pilonidal disease, hemorrhoids, and piles, and are distributed through home healthcare retail channels across Canada. The enterprise was established in 1998 and maintains its principal offices in Ottawa, Canada.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -92.86% | -99.99% | -99.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Devices: +11.2%+19.7% ★
-
EPS growth Medical - Devices: +28.5%—
-
FCF margin FCF growth · Medical - Devices: +30.9%-29.4%
-
EBIT margin Medical - Devices: +6.2%-95.8%
-
ROIC Medical - Devices: +3.3%—
-
Share dilution Medical - Devices: 0.0%—
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-1.95×
Executive team
Executive team data is not available for this company yet.
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VRSYF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
